User profiles for J. Nkwocha

Jewel Nkwocha

Virginia Commonwealth University
Verified email at vcu.edu
Cited by 160

Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells

M Rahmani, J Nkwocha, E Hawkins, X Pei, RE Parker… - Cancer research, 2018 - AACR
Inhibitors targeting BCL-2 apoptotic proteins have significant potential for the treatment of
acute myeloid leukemia (AML); however, complete responses are observed in only 20% of …

Inflammation and monocyte recruitment due to aging and mechanical stretch in alveolar epithelium are inhibited by the molecular chaperone 4-phenylbutyrate

…, MB Schneck, K Shankar, J Nkwocha… - Cellular and molecular …, 2018 - Springer
Introduction Ventilator-Induced lung injury (VILI) is a form of acute lung injury that is initiated
or exacerbated by mechanical ventilation. The aging lung is also more susceptible to injury. …

IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB–and caspase-8–dependent mechanisms

…, J Nkwocha, R Parker, D Bui, J McCarter… - Blood …, 2021 - ashpublications.org
Interactions between the inhibitor of apoptosis protein antagonist LCL161 and the histone
deacetylase inhibitor panobinostat (LBH589) were examined in human multiple myeloma (MM…

Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax

T Satta, L Li, SL Chalasani, X Hu, J Nkwocha… - Clinical Cancer …, 2023 - AACR
Purpose: Acute myelogenous leukemia (AML) is an aggressive disease with a poor outcome.
We investigated mechanisms by which the anti-AML activity of ABT-199 (venetoclax) could …

Chk1 inhibition potently blocks STAT3 Tyrosine705 Phosphorylation, DNA-Binding activity, and activation of downstream targets in human multiple myeloma Cells

…, X Hu, SL Chalasani, K Sharma, J Nkwocha, J Yu… - Molecular Cancer …, 2022 - AACR
These findings identify a heretofore unrecognized link between the Chk1 and STAT3
pathways and suggest that Chk1 pathway inhibitors warrant attention as novel and potent …

Causes of death in patients with Burkitt's lymphoma-the role of supportive care in overall management.

IT Magrath, C Semawere, J Nkwocha - East African Medical Journal, 1974 - cabdirect.org
A retrospective survey of the cause of death in 84 patients with Burkitt's lymphoma (BL) has
shown that these fall into early and late categories. The former are patients with tumours …

[HTML][HTML] Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells

X Hu, L Li, J Nkwocha, K Sharma, L Zhou, S Grant - Hematology Reports, 2023 - mdpi.com
Interactions between the novel hypomethylating agent (HMA) thio-deoxycytidine (T-dCyd)
and the BCL-2 antagonist ABT-199 (venetoclax) have been examined in human …

Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or‐resistant …

Y Leng, X Hu, L Li, J Nkwocha, T Satta… - Hematological …, 2022 - Wiley Online Library
… Yun Leng, Xiaoyan Hu and Lin Li performed in vitro and in vivo studies, carried out statistical
analyses, designed the figures, and wrote the manuscript; Jewel Nkwocha and Kanika …

[HTML][HTML] Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells

L Li, X Hu, J Nkwocha, K Sharma, M Kmieciak… - Cellular Oncology, 2023 - Springer
Purpose The goal of this study was to characterize the relationship between ATR and
STAT3 interactions in human multiple myeloma (MM) cells. Methods Various MM cell lines, …

Functional role of DNMT1 in the anti-leukemic effects of hypomethylating agents in AML cells

L Li, X Hu, J Nkwocha, K Sharma, L Zhou, S Grant - Leukemia Research, 2022 - Elsevier
Patients with high-risk MDS (myelodysplastic syndrome) respond poorly to current therapies,
and generally die due to progression to AML (acute myelogenous leukemia) or succumb to …